Long-Term Effectiveness Associated With Fecal Immunochemical Testing for Early-Age Screening | #CancerScreening, Prevention, Control | JAMA Oncology | JAMA Network https://jamanetwork.com/journals/jamaoncology/fullarticle/2835051 “In this cohort study including 263 125, fecal immunochemical test (#FIT) screening initiated at age 40 to 49 years followed by screening after age 50 years was associated with a 39% and 21% reduction in CRC mortality and incidence, respectively, compared with starting screening at age 50 years”